NCT07110259View on ClinicalTrials.gov

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

NANot yet recruitingINTERVENTIONAL
Enrollment

950

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Non Small Cell Lung Caner
Interventions
OTHER

DeepGEM-guided Molecular Testing and Treatment

Artificial intelligence-based mutation prediction using DeepGEM to guide clinical decision-making for molecular testing and therapy selection.

OTHER

Standard Diagnostic Pathway

DeepGEM is used for eligibility screening, but its results are withheld. Clinicians manage patients per standard diagnostic and treatment practices.

All Listed Sponsors
collaborator

Guangzhou Kingmed Diagnostics Co., Ltd.

UNKNOWN

lead

Jianxing He

OTHER

NCT07110259 - AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study | Biotech Hunter | Biotech Hunter